Literature DB >> 11163884

Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path?

A Copani1, D Uberti, M A Sortino, V Bruno, F Nicoletti, M Memo.   

Abstract

Cell-cycle-related proteins, such as cyclins or cyclin-dependent kinases, are re-expressed in neurons committed to death in response to a variety of insults, including excitotoxins, hypoxia and ischemia, loss of trophic support, or beta-amyloid peptide. In some of these conditions events that are typical of the mid-G1 phase, such as cyclin-dependent kinase 4/6 activation, are required for the induction of neuronal death. In other cases, the cycle must proceed further and recruit steps that are typical of the G1/S transition for death to occur. Finally, there are conditions in which cell-cycle proteins might be re-expressed, but do not contribute to neuronal death. We hypothesize that cell-cycle signaling becomes a mandatory component of neuronal demise when other mechanisms are not enough for neurons to reach the threshold for death. Under this scheme, the death threshold is set by the extent of DNA damage. Whenever the extent of DNA damage is below this threshold, a cell-cycle signaling becomes crucial for the induction of neuronal death through p53-dependent or -independent pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163884     DOI: 10.1016/s0166-2236(00)01663-5

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  61 in total

Review 1.  Adult neurogenesis in mammals: an identity crisis.

Authors:  Pasko Rakic
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 2.  Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death.

Authors:  Jaume Folch; Felix Junyent; Ester Verdaguer; Carme Auladell; Javier G Pizarro; Carlos Beas-Zarate; Mercè Pallàs; Antoni Camins
Journal:  Neurotox Res       Date:  2011-10-01       Impact factor: 3.911

3.  Activation of ataxia telangiectasia muted under experimental models and human Parkinson's disease.

Authors:  Antoni Camins; Javier G Pizarro; Daniel Alvira; Javier Gutierrez-Cuesta; Aurelio Vazquez de la Torre; Jaume Folch; Francesc X Sureda; Ester Verdaguer; Felix Junyent; Joaquín Jordán; Isidre Ferrer; Mercè Pallàs
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

4.  Cell and Context-Dependent Effects of the Heat Shock Protein DNAJB6 on Neuronal Survival.

Authors:  Chad Smith; Santosh R D'Mello
Journal:  Mol Neurobiol       Date:  2015-10-17       Impact factor: 5.590

Review 5.  Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis.

Authors:  Rachael L Neve; Donna L McPhie
Journal:  Biochim Biophys Acta       Date:  2006-10-18

6.  Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.

Authors:  Patricia Del Cerro; Carolina Alquézar; Fernando Bartolomé; Pedro González-Naranjo; Concepción Pérez; Eva Carro; Juan A Páez; Nuria E Campillo; Ángeles Martín-Requero
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

7.  Cell cycle activation and CNS injury.

Authors:  Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  Neurotox Res       Date:  2009-04-21       Impact factor: 3.911

8.  Chronically increased transforming growth factor-beta1 strongly inhibits hippocampal neurogenesis in aged mice.

Authors:  Marion S Buckwalter; Makiko Yamane; Bronwen S Coleman; Brandi K Ormerod; Jocelyn T Chin; Theo Palmer; Tony Wyss-Coray
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 9.  Class IIA HDACs in the regulation of neurodegeneration.

Authors:  Nazanin Majdzadeh; Brad E Morrison; Santosh R D'Mello
Journal:  Front Biosci       Date:  2008-01-01

10.  Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons.

Authors:  Da-Zhi Liu; Xi-Yuan Cheng; Bradley P Ander; Huichun Xu; Ryan R Davis; Jeffrey P Gregg; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2008-02-09       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.